Sziklavari Zsolt, Ried Michael, Neu Reiner, Schemm Rudolf, Grosser Christian, Szöke Tamas, Hofmann Hans-Stefan
Department of Thoracic Surgery, Hospital Barmherzige Brüder Regensburg, Regensburg, Germany
Department of Thoracic Surgery, University Regensburg, Regensburg, Germany.
Eur J Cardiothorac Surg. 2015 Aug;48(2):e9-16. doi: 10.1093/ejcts/ezv186. Epub 2015 May 27.
This prospective study is an evaluation of the mini-open vacuum-assisted closure with instillation (Mini-VAC-Instill) therapy for the treatment of complicated pleural empyema.
We investigated septic patients in poor general physical condition (Karnofsky index ≤50%) with multimorbidity and/or immunosuppression who were treated by minimally invasive intrathoracic VAC-Instill therapy without the insertion of an open-window thoracostomy (OWT) between December 2012 and November 2014. All patients underwent mini-thoracotomy with position of a tissue retractor, surgical debridement and local decortication. Surgery was followed by intrathoracic vacuum therapy including periodic instillation using antiseptics. The VAC dressings were changed under general anaesthesia and the chest wall was closed during the same hospital stay. All patients received systemic antibiotic therapy.
Fifteen patients (13 males, median age: 71 years) underwent intrathoracic Mini-VAC-Instill dressings for the management of pleural empyema without bronchopleural fistula. The median length of vacuum therapy was 9 days (5-25 days) and the median number of VAC changes per patient was 1 (1-5). In-hospital mortality was 6.7% (n = 1) and was not related to Mini-VAC-Instill therapy or intrathoracic infection. Control of intrathoracic infection and closure of the chest cavity was achieved in 85.7% of surviving patients (12 of 14). After the follow-up at an average of 13.2 months (range, 3-25 months), we observed recurrence once, 21 days after discharge. Two patients died in the late postoperative period (Day 43 and Day 100 after discharge) of fulminant urosepsis and carcinoma-related multiorgan failure, respectively. Analysis of the follow-up interviews in the outpatient clinic showed a good quality of life and a subjectively good long-term aesthetic result.
Mini-VAC-Instill therapy is an upgrade of Mini-VAC, which guarantees the advantage of an open treatment, including flushing but without OWT. This procedure is minimally invasive, highly compatible especially with patients in poor general condition and may be an alternative to the OWT in selected patients. Consequently, a very short course of therapy results in good patient acceptance.
本前瞻性研究旨在评估微创开放式负压封闭引流联合滴注疗法(Mini-VAC-Instill)治疗复杂性胸腔脓胸的效果。
我们调查了2012年12月至2014年11月期间接受微创胸腔内VAC-Instill治疗且未行开窗胸廓造口术(OWT)的全身状况较差(卡诺夫斯基指数≤50%)、患有多种疾病和/或免疫抑制的脓毒症患者。所有患者均接受了小切口开胸手术,放置组织牵开器,进行手术清创和局部剥脱术。手术后进行胸腔内负压治疗,包括定期滴注抗菌剂。VAC敷料在全身麻醉下更换,胸壁在同一住院期间关闭。所有患者均接受全身抗生素治疗。
15例患者(13例男性,中位年龄:71岁)接受胸腔内Mini-VAC-Instill敷料治疗胸腔脓胸,无支气管胸膜瘘。负压治疗的中位时间为9天(5-25天),每位患者VAC更换的中位次数为1次(1-5次)。住院死亡率为6.7%(n = 1),与Mini-VAC-Instill治疗或胸腔内感染无关。85.7%的存活患者(14例中的12例)实现了胸腔内感染的控制和胸腔闭合。平均随访13.2个月(范围3-25个月)后,我们观察到1例出院后21天复发。2例患者分别在术后晚期(出院后第43天和第100天)死于暴发性泌尿道感染和癌症相关的多器官功能衰竭。门诊随访访谈分析显示患者生活质量良好,长期美学效果主观良好。
Mini-VAC-Instill疗法是Mini-VAC的升级版,保证了开放式治疗的优势,包括冲洗但无需OWT。该手术微创,与全身状况较差的患者高度兼容,可能是部分患者OWT的替代方法。因此,疗程非常短,患者接受度良好。